INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,533 | +19.7% | 1,130 | 0.0% | 0.00% | – |
Q2 2023 | $23,843 | +23.8% | 1,130 | 0.0% | 0.00% | – |
Q1 2023 | $19,267 | -14.7% | 1,130 | 0.0% | 0.00% | – |
Q4 2022 | $22,577 | -5.9% | 1,130 | 0.0% | 0.00% | – |
Q3 2022 | $24,000 | +9.1% | 1,130 | 0.0% | 0.00% | – |
Q2 2022 | $22,000 | -18.5% | 1,130 | 0.0% | 0.00% | – |
Q1 2022 | $27,000 | -12.9% | 1,130 | 0.0% | 0.00% | – |
Q4 2021 | $31,000 | 0.0% | 1,130 | 0.0% | 0.00% | – |
Q3 2021 | $31,000 | -3.1% | 1,130 | 0.0% | 0.00% | – |
Q2 2021 | $32,000 | -15.8% | 1,130 | 0.0% | 0.00% | – |
Q1 2021 | $38,000 | 0.0% | 1,130 | 0.0% | 0.00% | – |
Q4 2020 | $38,000 | +5.6% | 1,130 | 0.0% | 0.00% | – |
Q3 2020 | $36,000 | +16.1% | 1,130 | 0.0% | 0.00% | – |
Q2 2020 | $31,000 | +72.2% | 1,130 | 0.0% | 0.00% | – |
Q1 2020 | $18,000 | -33.3% | 1,130 | 0.0% | 0.00% | – |
Q4 2019 | $27,000 | +35.0% | 1,130 | 0.0% | 0.00% | – |
Q3 2019 | $20,000 | -31.0% | 1,130 | 0.0% | 0.00% | – |
Q2 2019 | $29,000 | -12.1% | 1,130 | 0.0% | 0.00% | – |
Q1 2019 | $33,000 | +120.0% | 1,130 | 0.0% | 0.00% | – |
Q4 2018 | $15,000 | -34.8% | 1,130 | 0.0% | 0.00% | – |
Q3 2018 | $23,000 | -14.8% | 1,130 | 0.0% | 0.00% | – |
Q2 2018 | $27,000 | +8.0% | 1,130 | 0.0% | 0.00% | – |
Q1 2018 | $25,000 | -28.6% | 1,130 | 0.0% | 0.00% | – |
Q4 2017 | $35,000 | +133.3% | 1,130 | 0.0% | 0.00% | – |
Q4 2016 | $15,000 | -6.2% | 1,130 | 0.0% | 0.00% | – |
Q3 2016 | $16,000 | +45.5% | 1,130 | 0.0% | 0.00% | – |
Q2 2016 | $11,000 | -21.4% | 1,130 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | -33.3% | 1,130 | 0.0% | 0.00% | – |
Q4 2015 | $21,000 | 0.0% | 1,130 | 0.0% | 0.00% | – |
Q3 2015 | $21,000 | -25.0% | 1,130 | 0.0% | 0.00% | – |
Q2 2015 | $28,000 | +16.7% | 1,130 | 0.0% | 0.00% | – |
Q1 2015 | $24,000 | +41.2% | 1,130 | 0.0% | 0.00% | – |
Q4 2014 | $17,000 | +13.3% | 1,130 | 0.0% | 0.00% | – |
Q3 2014 | $15,000 | -34.8% | 1,130 | 0.0% | 0.00% | – |
Q2 2014 | $23,000 | +4.5% | 1,130 | 0.0% | 0.00% | – |
Q1 2014 | $22,000 | -21.4% | 1,130 | -30.7% | 0.00% | – |
Q4 2013 | $28,000 | – | 1,630 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |